Drug Type Small molecule drug |
Synonyms Diurisa |
Target |
Action inhibitors |
Mechanism ENaCα inhibitors(sodium channel epithelial 1 subunit alpha inhibitors), NKCC2 inhibitors(Sodium-(potassium)-chloride cotransporter 2 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC6H11Cl2N7O2 |
InChIKeyWDZJJRLYFQNCQL-UHFFFAOYSA-N |
CAS Registry17440-83-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Edema, Cardiac | Phase 3 | Brazil | 01 Jan 2011 |